Ann Bradstreet Joins Agency
COLUMBUS, Ohio–January 1, 2010– Stonefly Communications Group, an inVentiv Health company (NASDAQ:VTIV) and a patient-focused, insight-driven health and well-being advertising agency, recently announced a new appointment to the agency.
Ann Bradstreet has been named account director and will be responsible for managing agency teams for several key accounts, as well as her clients’ key online franchises. Prior to Stonefly, Bradstreet served as account supervisor for GSW Worldwide, where she worked on the award-winning prelaunch and launch of Cymbalta® and the launch of Sarafem®, as well as Xanodyne Pharmaceuticals and Dyax Corporation accounts, among others. Bradstreet began her career managing national promotions and development for Miller Brewing Company and Shell Oil Company.
“We are very pleased to have Ann join our agency, bringing with her a strong account service background, extensive experience with a wide variety of brands within the health care industry, as well as her entrepreneurial spirit,” said John Racik, president and CEO of Stonefly. “Her role in leading these particular account teams allows us to continue providing the focus, attention, service, and results our clients have come to expect from Stonefly.” |
